Articles related to MEDICAL MEETINGS AND EVENTS

FIL-ROUGE trial data presented at the International Conference on Malignant Lymphoma 2023 highlight the potential of intensified ABVD in improving outcomes for untreated Hodgkin lymphoma patients. Further exploration of this regimen’s long-term toxicity is anticipated.

Explore the groundbreaking findings from the TROPiCS-02 study, revealing sacituzumab govitecan as a potential game-changer in the treatment of endocrine refractory metastatic hormone receptor-positive breast cancer.

On July 11, 2023, participate in the AMCP PIE Webinar to learn more about the potential of VP-102, an investigational medication for molluscum contagiosum that is now undergoing FDA assessment.

Unpacking the landmark summit led by the American Pharmacists Association, it becomes clear that there is a pressing need and opportunity to expand healthcare coverage for pharmacists’ patient care services, promising substantial impacts on patient care and health systems.

Understand the profound implications of Dr. Vidal’s latest research on racial disparities in NGS testing for advanced non-small cell lung cancer, revealing a systemic issue that spans across practices and extends to the level of individual physicians.

Explore the latest findings from the VESPER trial that suggest a promising shift in bladder cancer treatment strategy, potentially setting a new standard for neoadjuvant therapy.